Abstract
Purpose
Treatment of secondary glaucoma in uveitis patients is challenging. Owing to the young age of these patients, sufficient lowering of the intraocular pressure (IOP) is essential to prevent progression of visual field loss. However, because of the chronic inflammatory stimulus, filtration surgery has an increased risk of failure, especially in patients who have previously undergone surgery. Therefore, minimally invasive glaucoma surgery is a valuable alternative.
Methods
The clinical records of 24 consecutive patients with uveitic secondary glaucoma who underwent trabeculectomy ab interno with the Trabectome® at the Eye Center of the Albert-Ludwigs University of Freiburg between June 2009 and June 2014 (registered in the Freiburg trabectome database) were retrospectively analyzed. The general baseline information for each patient included age, gender, glaucoma type, ocular medication and current IOP. The postoperative IOP and number of antiglaucomatous medications were recorded at each visit. Statistical analyses were performed using the Kaplan-Meier estimator and Dunnett’s t-test.
Results
The mean IOP before surgery was 31 ± 6.7 mmHg (median 32 mmHg). Both the IOP and the number of medications significantly decreased over the various follow-up intervals after trabeculectomy ab interno with the Trabectome®. Patients with follow-ups continuing past one year showed an IOP-reduction of approximately 40 % and a medication number reduction from 2 to 0.67. The failure rate (necessitating further glaucoma surgery) was N = 3 (12.5 %) patients.
Conclusions
Trabeculectomy ab interno with the Trabectome® is a minimally invasive and effective method for controlling IOP in uveitic secondary glaucoma.
Similar content being viewed by others
References
Beer G (1813) Die Lehrer v. d. Augenkrankheiten. Vienna
Mackensen F, Paulus WE, Max R, Ness T (2014) Ocular changes during pregnancy. Dtsch Arztebl Int 111:567–576. doi:10.3238/arztebl.2014.0567
Moorthy RS, Mermoud A, Baerveldt G et al (1997) Glaucoma associated with uveitis. Surv Ophthalmol 41:361–394
Stavrou P, Murray PI (1999) Long-term follow-up of trabeculectomy without antimetabolites in patients with uveitis. Am J Ophthalmol 128:434–439
Carreno E, Villaron S, Portero A et al (2010) Surgical outcomes of uveitic glaucoma. J Ophthalmic Inflamm Infect 1:43–53. doi:10.1007/s12348-010-0012-8
Hill RA, Nguyen QH, Baerveldt G et al (1993) Trabeculectomy and Molteno implantation for glaucomas associated with uveitis. Ophthalmology 100:903–908
Ceballos EM, Parrish RK 2nd, Schiffman JC (2002) Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma. Ophthalmology 109:2256–2260
Da Mata A, Burk SE, Netland PA et al (1999) Management of uveitic glaucoma with Ahmed glaucoma valve implantation. Ophthalmology 106:2168–2172. doi:10.1016/S0161-6420(99)90500-6
Papadaki TG, Zacharopoulos IP, Pasquale LR et al (2007) Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol 144:62–69. doi:10.1016/j.ajo.2007.03.013
Herbert HM, Viswanathan A, Jackson H, Lightman SL (2004) Risk factors for elevated intraocular pressure in uveitis. J Glaucoma 13:96–99
Armaly MF, Becker B (1965) Intraocular pressure response to topical corticosteroids. Fed Proc 24:1274–1278
Francis BA, See RF, Rao NA et al (2006) Ab interno trabeculectomy: development of a novel device (Trabectome) and surgery for open-angle glaucoma. J Glaucoma 15:68–73
Minckler DS, Baerveldt G, Alfaro MR, Francis BA (2005) Clinical results with the Trabectome for treatment of open-angle glaucoma. Ophthalmology 112:962–967. doi:10.1016/j.ophtha.2004.12.043
Jordan JF, Wecker T, van Oterendorp C et al (2013) Trabectome surgery for primary and secondary open angle glaucomas. Graefes Arch Clin Exp Ophthalmol 251:2753–2760. doi:10.1007/s00417-013-2500-7
Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457
Dunnett CW (1955) A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 50:1096–1121
Dunnett CW (1964) New tables for multiple comparisons with a control. Biometrics 20:482–491
Kiddee W, Trope GE, Sheng L et al (2013) Intraocular pressure monitoring post intravitreal steroids: a systematic review. Surv Ophthalmol 58:291–310. doi:10.1016/j.survophthal.2012.08.003
Marcus MW, Müskens RPHM, Ramdas WD et al (2012) Corticosteroids and open-angle glaucoma in the elderly: a population-based cohort study. Drugs Aging 29:963–970. doi:10.1007/s40266-012-0029-9
Siddique SS, Suelves AM, Baheti U, Foster CS (2013) Glaucoma and uveitis. Surv Ophthalmol 58:1–10. doi:10.1016/j.survophthal.2012.04.006
Bodh S, Kumar V, Raina U et al (2011) Inflammatory glaucoma. Oman J Ophthalmol 4:3. doi:10.4103/0974-620X.77655
Towler HM, McCluskey P, Shaer B, Lightman S (2000) Long-term follow-up of trabeculectomy with intraoperative 5-fluorouracil for uveitis-related glaucoma. Ophthalmology 107:1822–1828
Jampel HD, Jabs DA, Quigley HA (1990) Trabeculectomy with 5-fluorouracil for adult inflammatory glaucoma. Am J Ophthalmol 109:168–173
Patitsas CJ, Rockwood EJ, Meisler DM, Lowder CY (1992) Glaucoma filtering surgery with postoperative 5-fluorouracil in patients with intraocular inflammatory disease. Ophthalmology 99:594–599
Kaburaki T, Koshino T, Kawashima H et al (2009) Initial trabeculectomy with mitomycin C in eyes with uveitic glaucoma with inactive uveitis. Eye (Lond) 23:1509–1517. doi:10.1038/eye.2009.117-cme
Hill RA, Heuer DK, Baerveldt G et al (1991) Molteno implantation for glaucoma in young patients. Ophthalmology 98:1042–1046
Rachmiel R, Trope GE, Buys YM et al (2008) Ahmed glaucoma valve implantation in uveitic glaucoma versus open-angle glaucoma patients. Can J Ophthalmol 43:462–467. doi:10.3129/i08-082
Ozdal PC, Vianna RNG, Deschênes J (2006) Ahmed valve implantation in glaucoma secondary to chronic uveitis. Eye (Lond) 20:178–183. doi:10.1038/sj.eye.6701841
Barton K, Feuer WJ, Budenz DL et al (2014) Three-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology 121:1547–1557. doi:10.1016/j.ophtha.2014.01.036, e1
Bailey AK, Sarkisian SR (2014) Complications of tube implants and their management. Curr Opin Ophthalmol 25:148–153. doi:10.1097/ICU.0000000000000034
Freedman SF, Rodriguez-Rosa RE, Rojas MC, Enyedi LB (2002) Goniotomy for glaucoma secondary to chronic childhood uveitis. Am J Ophthalmol 133:617–621
Jea SY, Mosaed S, Vold SD, Rhee DJ (2012) Effect of a failed trabectome on subsequent trabeculectomy. J Glaucoma 21:71–75. doi:10.1097/IJG.0b013e31820bcfda
Brandao LM, Grieshaber MC (2013) Update on minimally invasive glaucoma surgery (MIGS) and new implants. J Ophthalmol. doi:10.1155/2013/705915
Kaplowitz K, Schuman JS, Loewen NA (2014) Techniques and outcomes of minimally invasive trabecular ablation and bypass surgery. Br J Ophthalmol 98:579–585. doi:10.1136/bjophthalmol-2013-304256
Hueber A, Roters S, Jordan JF, Konen W (2013) Retrospective analysis of the success and safety of Gold Micro Shunt Implantation in glaucoma. BMC Ophthalmol 13:35. doi:10.1186/1471-2415-13-35
Unal M, Kocak Altintas AG, Koklu G, Tuna T (2011) Early results of suprachoroidal drainage tube implantation for the surgical treatment of glaucoma. J Glaucoma 20:307–314. doi:10.1097/IJG.0b013e3181e3d30f
Roberts CW (1993) Intraocular miotics and postoperative inflammation. J Cataract Refract Surg 19:731–734
Acknowledgments
The results of this study were presented at the DOG (German Ophthalmological Society) in September 2014 in Leipzig
Financial disclosure
None of the authors has any proprietary or financial interests.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Anton, A., Heinzelmann, S., Neß, T. et al. Trabeculectomy ab interno with the Trabectome® as a therapeutic option for uveitic secondary glaucoma. Graefes Arch Clin Exp Ophthalmol 253, 1973–1978 (2015). https://doi.org/10.1007/s00417-015-3102-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00417-015-3102-3